IRTC (iRhythm Technologies, Inc.) רווח למניה בארבעת הרבעונים האחרונים

iRhythm Technologies (IRTC) is recognized as a leader in arrhythmia diagnostics due to its high-precision wearable sensors. Growth is driven by the expansion of Zio Patch and the integration of AI into primary care. However, heavy reliance on a single product creates risks that are mitigated by software development. The YoY change in EPS on a rolling 12-month basis demonstrates profit dynamics, where the current status is 28.40.

For iRhythm Technologies (IRTC), a leader in AI-driven arrhythmia monitoring, the YoY eps volatility over the last 12 months on GURU.Markets reflects the scaling pace of earnings per share relative to the same period last year. This TTM indicator neutralizes quarterly volatility, allowing investors to assess the actual efficiency of Zio patches displacing traditional Holters and determine the fair value of the business without market distortions.